POPULATION MODEL CONFIRMS PREDICTABLE PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) PROFILE FOR APRAGLUTIDE - DATA FROM TWO RANDOMIZED PHASE 1 STUDIES

被引：0
|
作者：
Bolognani, Federico
Machacek, Matthias
Kruithof, Annelieke
de Kam, Marieke L.
Bergmann, Kirsten
van Gent, Max
Moerland, Matthijs
Crenn, Pascal
Greig, Christian Meyer Gerard
Gal, Pim
Schulthess, Pascal
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su559
引用
下载
收藏
页码：S738 / S738
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetic Profile of Armodafinil in Healthy Subjects Pooled Analysis of Data from Three Randomized Studies
    Darwish, Mona
    Kirby, Mary
    Hellriegel, Edward T.
    Yang, Ronghua
    Robertson, Philmore, Jr.
    CLINICAL DRUG INVESTIGATION, 2009, 29 (02) : 87 - 100
  • [42] Pharmacokinetic, pharmacodynamic, and safety profiles of PEGylated interferon beta-1a in healthy volunteers: Results from two Phase 1 clinical studies
    Davar, Gudarz
    Richman, Sandra
    Hitchman, Stacy
    Glick, Gabrielle
    Subramanyam, Meena
    Hu, Xiao
    Lerner, Michaela
    Miller, Larisa
    Nestorov, Ivan
    Liu, Shifang
    Zhu, Ying
    Baker, Darren
    Panzara, Michael A.
    CYTOKINE, 2009, 48 (1-2) : 21 - 21
  • [43] Pharmacokinetic, pharmacodynamic, and safety profiles of PEGylated interferon beta-1a in healthy volunteers: results from two phase 1 clinical studies
    Davar, G.
    Richman, S.
    Hitchman, S.
    Glick, G.
    Subramanyam, M.
    Hu, X.
    Lerner, M.
    Miller, L.
    Nestorov, I.
    Liu, S.
    Zhu, Y.
    Panzara, M. A.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S125 - S125
  • [44] Pharmacokinetic and pharmacokinetic/pharmacodynamic characterization of the dolutegravir/rilpivirine two-drug regimen in SWORD-1/-2 phase 3 studies
    Mehta, Rashmi
    Lagishetty, Chakradhar V.
    Angelis, Konstantinos
    Aylott, Alicia
    Kahl, Lesley
    Blair, Libby
    Matthews, Jessica
    Wynne, Brian
    Crauwels, Herta
    Underwood, Mark
    Adkison, Kimberly K.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (07) : 2190 - 2200
  • [45] A phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of CHIR-258, a novel oral multiple receptor tyrosine kinase (RTK) inhibitor.
    Sarker, D.
    Evans, J.
    Hardie, M.
    Molife, R.
    Marriott, C.
    Morrison, R.
    Garzon, F.
    Heise, C.
    Michelson, G.
    De-Bono, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 131S - 131S
  • [46] Phase 1b/2 Pharmacokinetic/Pharmacodynamic (PK/PD) Study of Combination Voreloxin and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia Patients
    Lancet, Jeffrey E.
    Roboz, Gail J.
    Cripe, Larry D.
    Maris, Michael
    List, Alan F.
    Fox, Judith
    Michelson, Glenn C.
    Karp, Judith
    BLOOD, 2009, 114 (22) : 263 - 264
  • [47] Pharmacokinetic (PK) and pharmacodynamic (PD) results from two phase I studies of the investigational selective Aurora A kinase (AAK) inhibitor MLN8237: Exposure-dependent AAK inhibition in human tumors.
    Cervantes-Ruiperez, A.
    Burris, H. A., III
    Cohen, R. B.
    Dees, E. C.
    Infante, J. R.
    Fingert, H. J.
    Shinde, V.
    Venkatakrishnan, K.
    Chakravarty, A.
    Tabernero, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Bioequivalence Studies of Omnitrope, the First Biosimilar/rhGH Follow-on Protein: Two Comparative Phase 1 Randomized Studies and Population Pharmacokinetic Analysis
    Stanhope, Richard
    Soergel, Fritz
    Gravel, Patricia
    Schuetz, Yannic B. Pannatier
    Zabransky, Markus
    Muenzberg, Michael
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (11): : 1339 - 1348
  • [49] BIOEQUIVALENCE OF A NEW BIOSIMILAR FILGRASTIM AND NEUPOGEN: PHARMACOKINETIC, PHARMACODYNAMIC AND SAFETY DATA FROM TWO RANDOMISED, PHASE I, HEALTHY-VOLUNTEER STUDIES
    Waller, C. F.
    Bronchud, M. H.
    Mair, S. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 230 - 230
  • [50] Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies
    Trang, Michael
    Seroogy, Julie D.
    Van Wart, Scott A.
    Bhavnani, Sujata M.
    Kim, Aryun
    Gibbons, Jacqueline A.
    Ambrose, Paul G.
    Rubino, Christopher M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
12345